Phytochemical Profiling and Anticancer Potential of Fagonia cretica L. Extract on Liver Cancer (Hepg2) Cells using In vitro and In silico Approaches.

IF 2.6 4区 医学 Q3 CHEMISTRY, MEDICINAL
Fatima Arshad, Awais Altaf, Ali Raza Arshad, Asia Kiran, Muhammad Sarwar, Sumaira Sharif, Tahir Maqbool, Turki S Abujamel, Absarul Haque, Muhammad Imran Naseer
{"title":"Phytochemical Profiling and Anticancer Potential of Fagonia cretica L. Extract on Liver Cancer (Hepg2) Cells using In vitro and In silico Approaches.","authors":"Fatima Arshad, Awais Altaf, Ali Raza Arshad, Asia Kiran, Muhammad Sarwar, Sumaira Sharif, Tahir Maqbool, Turki S Abujamel, Absarul Haque, Muhammad Imran Naseer","doi":"10.2174/0118715206377419250527105350","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cancer is a complex multifactorialdisease charcterized by the progression of genetic and epigenetic changes in human cells . Plant-based derivatives with antioxidant and anticancer properties have been of great interest in treating several human ailments.</p><p><strong>Objective: </strong>This study investigates the in-vitro antioxidative, cytotoxic, and apoptotic activities of different Fagonia cretica L. (F. cretica) leaf extracts.</p><p><strong>Methods: </strong>In-vitro DPPH, nitric oxide, superoxide anion, and hydrogen peroxide assays were used to evaluate the antioxidative potential of ethanolic extract of F. cretica (EFC) and hexane extract of F. cretica (HFC). The antiproliferative potential was determined using MTT, crystal violet, and annexin V/PI staining protocols on liver cancer (HepG2) and noncancerous (HEK-293) cell lines. Through In silico analysis, bioactive drug-like phytocompounds identified by GC-MS were evaluated.</p><p><strong>Results: </strong>Higher concentrations of total flavonoid contents (TFCs), total phenolic contents (TPCs), and tannins with strong antioxidant potential were observed in EFC extract as compared to HFC extract. Furthermore, the EFC extract proved to be more cytotoxic with a selective index (SI) of 12.92 than HFC (SI; 5.46) towards experimental cell lines. Moreover, EFC extract showed 82.31% apoptotic induction on HepG2 cells compared to hexane extract and cisplatin (standard drug). From the GC-MS analysis of F. cretica, 32 bioactive compounds were identified from the EFC extract and 21 from the HFC extract. In silico study revealed that 5-(4,5-Dihydro-3Hpyrrol- 2-ylmethylene)-4,4-dimethylpyrrolidine-2-thione showed the highest docking score of -8.9 kcal/mol and - 8.6 kcal/mol against TNF-α and TGF-β, respectively.</p><p><strong>Conclusion: </strong>In conclusion, EFC extract and its bioactive compounds have a scientifically proven role in liver cancer management, but further research is required to validate their therapeutics through clinical trials.</p>","PeriodicalId":7934,"journal":{"name":"Anti-cancer agents in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anti-cancer agents in medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0118715206377419250527105350","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cancer is a complex multifactorialdisease charcterized by the progression of genetic and epigenetic changes in human cells . Plant-based derivatives with antioxidant and anticancer properties have been of great interest in treating several human ailments.

Objective: This study investigates the in-vitro antioxidative, cytotoxic, and apoptotic activities of different Fagonia cretica L. (F. cretica) leaf extracts.

Methods: In-vitro DPPH, nitric oxide, superoxide anion, and hydrogen peroxide assays were used to evaluate the antioxidative potential of ethanolic extract of F. cretica (EFC) and hexane extract of F. cretica (HFC). The antiproliferative potential was determined using MTT, crystal violet, and annexin V/PI staining protocols on liver cancer (HepG2) and noncancerous (HEK-293) cell lines. Through In silico analysis, bioactive drug-like phytocompounds identified by GC-MS were evaluated.

Results: Higher concentrations of total flavonoid contents (TFCs), total phenolic contents (TPCs), and tannins with strong antioxidant potential were observed in EFC extract as compared to HFC extract. Furthermore, the EFC extract proved to be more cytotoxic with a selective index (SI) of 12.92 than HFC (SI; 5.46) towards experimental cell lines. Moreover, EFC extract showed 82.31% apoptotic induction on HepG2 cells compared to hexane extract and cisplatin (standard drug). From the GC-MS analysis of F. cretica, 32 bioactive compounds were identified from the EFC extract and 21 from the HFC extract. In silico study revealed that 5-(4,5-Dihydro-3Hpyrrol- 2-ylmethylene)-4,4-dimethylpyrrolidine-2-thione showed the highest docking score of -8.9 kcal/mol and - 8.6 kcal/mol against TNF-α and TGF-β, respectively.

Conclusion: In conclusion, EFC extract and its bioactive compounds have a scientifically proven role in liver cancer management, but further research is required to validate their therapeutics through clinical trials.

体外和计算机方法研究火柴提取物对肝癌细胞(Hepg2)的植物化学特性和抗癌潜力。
背景:癌症是一种复杂的多因素疾病,以人类细胞遗传和表观遗传变化的进展为特征。具有抗氧化和抗癌特性的植物衍生物在治疗几种人类疾病方面引起了极大的兴趣。目的:研究不同荆芥叶提取物的体外抗氧化活性、细胞毒性和细胞凋亡活性。方法:采用体外DPPH法、一氧化氮法、超氧阴离子法和过氧化氢法评价牛蒡醇提物(EFC)和己烷提物(HFC)的抗氧化能力。采用MTT、结晶紫和膜联蛋白V/PI染色检测肝癌(HepG2)和非癌(HEK-293)细胞系的抗增殖潜能。通过硅片分析,对GC-MS鉴定的生物活性类药物植物化合物进行了评价。结果:EFC提取物的总黄酮含量(tfc)、总酚含量(tpc)和单宁含量均高于HFC提取物,具有较强的抗氧化活性。此外,EFC提取物比HFC (SI)具有更高的细胞毒性,其选择指数(SI)为12.92;5.46)实验细胞系。与正己烷提取物和顺铂(标准药物)相比,EFC提取物对HepG2细胞的诱导凋亡率为82.31%。通过GC-MS分析,从EFC提取物中鉴定出32种活性化合物,从HFC提取物中鉴定出21种活性化合物。结果表明,5-(4,5-二氢- 3hpyrrol -2-基亚甲基)-4,4-二甲基吡咯烷-2-硫酮对TNF-α和TGF-β的对接评分最高,分别为-8.9 kcal/mol和- 8.6 kcal/mol。结论:综上所述,EFC提取物及其生物活性化合物在肝癌的治疗中具有科学证实的作用,但还需要进一步的研究来通过临床试验验证其治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Anti-cancer agents in medicinal chemistry
Anti-cancer agents in medicinal chemistry ONCOLOGY-CHEMISTRY, MEDICINAL
CiteScore
5.10
自引率
3.60%
发文量
323
审稿时长
4-8 weeks
期刊介绍: Formerly: Current Medicinal Chemistry - Anti-Cancer Agents. Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication. Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信